• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not.

作者信息

Reiffel James A

机构信息

Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA.

出版信息

J Innov Card Rhythm Manag. 2019 Aug 15;10(8):3790-3792. doi: 10.19102/icrm.2019.100803. eCollection 2019 Aug.

DOI:10.19102/icrm.2019.100803
PMID:32494423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252818/
Abstract
摘要

相似文献

1
Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not.口服抗凝治疗：不该发生的却发生了，该发生的却未发生。
J Innov Card Rhythm Manag. 2019 Aug 15;10(8):3790-3792. doi: 10.19102/icrm.2019.100803. eCollection 2019 Aug.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.接受经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗栓治疗：北美视角：2021年更新
Circulation. 2021 Feb 9;143(6):583-596. doi: 10.1161/CIRCULATIONAHA.120.050438. Epub 2021 Feb 8.
4
Anticoagulant and Antiplatelet Prescribing Patterns for Patients with Atrial Fibrillation after Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后心房颤动患者的抗凝和抗血小板用药模式
Can J Hosp Pharm. 2016 Jul-Aug;69(4):280-5. doi: 10.4212/cjhp.v69i4.1574. Epub 2016 Aug 31.
5
[Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].[急性冠状动脉综合征住院房颤患者的抗凝状态、依从性及其对1年预后的影响：一项多中心队列研究]
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jul 24;51(7):731-741. doi: 10.3760/cma.j.cn112148-20230314-00138.
6
Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.经皮冠状动脉介入治疗后心房颤动合并冠状动脉疾病患者的抗栓治疗方案：聚焦综述
Int J Cardiol. 2017 Sep 15;243:263-269. doi: 10.1016/j.ijcard.2017.05.119. Epub 2017 Jun 2.
7
[Is it necessary to prescribe oral anticoagulant therapy for paroxysmal atrial fibrillation during acute coronary syndrome, and for how long?].急性冠状动脉综合征期间阵发性心房颤动是否需要口服抗凝治疗，以及治疗多久？
G Ital Cardiol (Rome). 2019 Jun;20(6):361-366. doi: 10.1714/3165.31469.
8
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble.经皮冠状动脉介入治疗后心房颤动的抗栓治疗：三重困境。
Drugs. 2018 Sep;78(13):1309-1319. doi: 10.1007/s40265-018-0957-8.
9
In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.美国房颤抗凝时代华法林和直接口服抗凝剂致心肌梗死患者院内出血结局：来自全国心血管数据注册急性冠脉治疗和干预结局网络注册的报告。
J Am Heart Assoc. 2019 Apr 16;8(8):e011606. doi: 10.1161/JAHA.118.011606.
10
Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.接受经皮冠状动脉介入治疗的非瓣膜性心房颤动患者预防长期主要不良心血管事件的抗栓策略。
Expert Opin Pharmacother. 2017 Jun;18(9):875-883. doi: 10.1080/14656566.2017.1329822. Epub 2017 May 22.

本文引用的文献

1
Anticoagulation Patterns in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention in an Academic Center.学术中心经皮冠状动脉介入治疗后心房颤动患者的抗凝模式
J Innov Card Rhythm Manag. 2019 Aug 15;10(8):3785-3789. doi: 10.19102/icrm.2019.100802. eCollection 2019 Aug.
2
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。
Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.
3
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.2018 年加拿大心血管学会心房颤动管理指南重点更新。
Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026.
4
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).2018 年欧洲共识文件：急性冠状动脉综合征和/或经皮心血管介入治疗的心房颤动患者抗栓治疗管理：欧洲心律协会（EHRA）、欧洲心脏病学会血栓工作组、欧洲经皮心血管介入协会（EAPCI）和欧洲急性心脏护理协会（ACCA）的联合共识文件，得到了心律学会（HRS）、亚太心律学会（APHRS）、拉丁美洲心律学会（LAHRS）和南非心脏心律失常学会（CASSA）的认可。
Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174.
5
Optimum Risk Assessment for Stroke in Atrial Fibrillation: Should We Hold the Status Quo or Consider Magnitude Synergism and Left Atrial Appendage Anatomy?心房颤动患者卒中的最佳风险评估：我们应维持现状还是考虑效应协同作用和左心耳解剖结构？
Arrhythm Electrophysiol Rev. 2017 Dec;6(4):161-166. doi: 10.15420/aer.2017.33.1.
6
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial.口服抗凝治疗的心房颤动患者的临床结局和跌倒史：来自 ARISTOTLE 试验的见解。
Am J Med. 2018 Mar;131(3):269-275.e2. doi: 10.1016/j.amjmed.2017.10.036. Epub 2017 Nov 6.
7
Risk of falls and major bleeds in patients on oral anticoagulation therapy.口服抗凝治疗患者的跌倒风险和大出血风险。
Am J Med. 2012 Aug;125(8):773-8. doi: 10.1016/j.amjmed.2012.01.033.